查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
诊断市场中的质谱和层析法分析 - 全球和区域分析：按产品类型、按应用类型、按样品类型、按测试类型、按地区 - 分析和预测 (2024-2033)
市场调查报告书
商品编码
1524904

诊断市场中的质谱和层析法分析 - 全球和区域分析：按产品类型、按应用类型、按样品类型、按测试类型、按地区 - 分析和预测 (2024-2033)

Mass Spectrometry and Chromatography in Diagnostics Market - A Global and Regional Analysis: Focus on Product Type, Application Type, Sample Type, Testing Type, and Region - Analysis and Forecast, 2024-2033
出版日期: | 出版商: BIS Research | 英文 199 Pages | 商品交期: 1-5个工作天内

价格

2023 年，全球质谱和层析法诊断市场规模为 7.431 亿美元。

预计2024年至2033年间，该市场将以9.92%的复合年增长率成长，到2033年将达到18.638亿美元。质谱 (MS) 和层析法市场都是更广泛的分析和生命科学仪器领域的重要组成部分。这两种技术都为化学物质和生物物质的分离、识别和定量提供了复杂的方法，并推动了製药、环境监测、诊断和食品安全等多个领域的进步。在诊断应用中，这些技术很少单独使用，而是整合到工作流程中。例如，液相层析法质谱仪将液相层析法的分离能力与质谱仪的质谱分析能力结合。这种整合在复杂样品分析中特别有效，在复杂样品分析中，在确定品质或结构之前需要分离成分。这种混合系统在临床实践中对于患者样本的高通量分析至关重要，可以提供全面的理解来指南诊断和治疗。质谱和层析法在诊断中的主要应用包括维生素分析和荷尔蒙分析。

主要市场统计数据
预测期 2024-2033
2024年评估 7.959 亿美元
2033年预测 18.638 亿美元
复合年增长率 9.92%

与传统免疫测量相比，诊断市场中的质谱和层析法正在经历快速增长，这些技术具有多种优势，而这些技术的持续技术进步将进一步推动我们的推广。然而，购买设备的高昂成本和缺乏熟练专业人员预计将阻碍市场的成长。

此外，人们正在转向使用液相层析法串联式质谱质谱 (LC-MS/MS) 作为诊断的标准技术。诊断领域对 LC-MS/MS 的日益偏好是由于其独特的分析优势，包括卓越的特异性、灵敏度以及执行复杂诊断任务所必需的多重测试的能力。除此之外，自动化样品製备系统在基于质谱的诊断中的整合是临床实验室业务的关键进步。由于对更快、更准确的诊断测试的需求不断增加以及技术的不断进步，预计这一趋势将继续增长。

该报告研究了全球诊断质谱和层析法市场，提供了市场概述、按产品类型、应用类型、样品类型、测试类型、区域和参与市场的公司分類的趋势等。

目录

执行摘要

第一章全球诊断质谱和层析法市场：产业展望

  • 市场概况
  • 主要趋势
  • 主要趋势的机会评估
  • 产品基准
  • 监管状况

第二章诊断市场中的全球质谱和层析法：市场动态

  • 影响分析
  • 市场驱动因素
  • 市场限制因素
  • 市场机会

第三章诊断市场中的全球质谱和层析法（按产品类型）

  • 产品类型概览
  • 成长占有率矩阵
  • 样品製备
  • 质谱和层析法

第四章诊断市场中的全球质谱和层析法（按应用​​类型）

  • 使用类型概述
  • 成长占有率矩阵
  • 治疗药物监测
  • 维他命
  • 荷尔蒙
  • 甲基丙二酸 (MMA)
  • 免疫抑制剂
  • 其他的

第五章诊断市场中的全球质谱和层析法（按样品类型）

  • 样本类型概述
  • 成长占有率矩阵
  • 血
  • 尿
  • 血清
  • 电浆
  • 唾液

第六章全球诊断质谱和层析法市场（按测试类型）

  • 考试类型概述
  • 成长占有率矩阵
  • 临床检查
  • 商业化验

第七章全球质谱和层析法诊断市场（按地区）

  • 区域概况
  • 促进因素和抑制因素
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章诊断市场中的全球质谱和层析法：竞争基准化分析和公司概况

  • 竞争格局
    • 伙伴关係、联盟和业务扩张
    • 新服务
    • 併购
    • 监理核准
  • 关键策略和发展
  • 企业竞赛矩阵
  • 企业市场占有率分析
  • 公司简介
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific, Inc.
    • Waters Corporation
    • Tecan Group Ltd.
    • Danaher Corporation
    • Shimadzu Corporation
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.
    • PerkinElmer Inc.
    • Promega Corporation
    • Restek Corporation
    • GERSTEL GmbH & Co. KG
    • Bruker Corporation
    • New England Biolabs
    • Hamilton Company
    • Avantor, Inc. (VWR International, LLC.)
    • Chromsystems Instruments & Chemicals GmbH.
    • RECIPE Chemicals + Instruments GmbH
    • Zivak
    • SENTINEL CH. SpA

第9章调查方法

Product Code: BHL2118SA

Global Mass Spectrometry and Chromatography in Diagnostics Market Industry Overview

The global mass spectrometry and chromatography in diagnostics market was valued at $743.1 million in 2023 and is expected to reach $1,863.8 million by 2033, growing at a CAGR of 9.92% between 2024 and 2033. The mass spectrometry (MS) and chromatography markets are critical components of the broader analytical and life sciences instrumentation sector. Both technologies offer sophisticated methods for the separation, identification, and quantification of chemical and biological substances and have been instrumental in driving advances across a variety of fields, including pharmaceuticals, environmental monitoring, diagnostics, and food safety, among others. For diagnostics applications, these technologies are mostly not used in isolation but are integrated into workflows. For instance, liquid chromatography-mass spectrometry combines the separation capabilities of liquid chromatography with the mass analysis power of mass spectrometry. This integration is particularly effective in complex sample analysis, where components need to be separated before their mass and structure can be determined. Such hybrid systems are critical in clinical settings for the high-throughput analysis of patient samples, offering a comprehensive understanding that guides diagnosis and treatment. The key applications of mass spectrometry and chromatography in diagnostics include vitamin profiling and hormone profiling, among others.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$795.9 Million
2033 Forecast$1,863.8 Million
CAGR9.92%

The mass spectrometry and chromatography in diagnostics market is experiencing rapid growth, driven by multiple benefits offered by the technologies as compared to the traditional immunoassays, and continuous technological advancements in these technologies are further advancing their adoption. However, the high cost of acquisition of instrumentations, as well as the dearth of skilled professionals, is expected to hinder the growth of the global mass spectrometry and chromatography in diagnostics market.

Furthermore, there has been a shift toward the utilization of liquid chromatography-tandem mass spectrometry (LC-MS/MS) as a standard technique in diagnostics. The growing preference for LC-MS/MS in diagnostics is driven by its unparalleled analytical advantages, which include exceptional specificity, sensitivity, and the ability to conduct multiplex testing, qualities that are indispensable for complex diagnostic tasks. In addition to this, the integration of automated sample preparation systems in mass spectrometry-based diagnostics marks a pivotal advancement in clinical laboratory operations. This trend will continue to expand, driven by the increasing demands for faster, more accurate diagnostic testing and the ongoing advancements in technology.

Industrial Impact

This technology has a pivotal role in diagnostics applications such as therapeutic drug monitoring, vitamin analysis, hormone profiling, newborn screening, and infectious diseases, among others.

Market Segmentation:

Segmentation 1: by Product Type

  • Sample Preparation
  • Mass Spectrometry and Chromatography

Mass Spectrometry and Chromatography Segment to Dominate the Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type)

The mass spectrometry and chromatography segment is poised to dominate the mass spectrometry and chromatography in diagnostics market based on product type. This dominance has been driven by the high cost of the instrumentations of mass spectrometry and chromatography and the recurring use of consumables in diagnostics.

Segmentation 2: by Application Type

  • Therapeutic Drug Monitoring
  • Vitamins
  • Hormones
  • Methylmalonic Acid
  • Immunosuppressants
  • Others

Others Segment to Dominate the Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type)

The others segment is positioned to dominate the mass spectrometry and chromatography in diagnostics market by application type. This predominance is largely due to the fact that newborn screening was one of the earliest applications of mass spectrometry and chromatography in diagnostics. These technologies have been integral to this field for a long time, making a significant contribution to the market.

Segmentation 3: by Sample Type

  • Blood
  • Urine
  • Serum
  • Plasma
  • Saliva

Serum to Dominate the Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Type)

The serum segment is positioned to dominate the mass spectrometry and chromatography in diagnostics market based on sample type due to its suitability for a broad spectrum of applications, from hormone profiling to vitamin analysis. This makes serum an ideal sample type for precise and comprehensive diagnostic tests.

Segmentation 4: by Testing Type

  • Laboratory-Developed Tests
  • Commercial Assays

Laboratory-Developed Tests to Dominate the Mass Spectrometry and Chromatography in Diagnostics Market (by Testing Type)

The laboratory-developed tests segment is positioned to dominate the mass spectrometry and chromatography in diagnostics market by testing type. On the other hand, the commercial assay segment is expected to be the fastest-growing segment, with a CAGR of 10.40% in the forecast period 2024-2033.

Segmentation 5: by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Spain
    • Italy
    • France
    • Rest-of-Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest-of-Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest-of-Middle East and Africa

The global mass spectrometry and chromatography in diagnostics market (by region) has been dominated by North America, which held 45.10% of the market share in 2023 and is anticipated to retain its position in the market during the forecast period. The region boasts an advanced healthcare infrastructure, particularly in the U.S., which facilitates the adoption of cutting-edge medical technologies, including mass spectrometry and chromatography. Additionally, North America is the hub to many leading companies in the mass spectrometry and chromatography in diagnostics market, such as Agilent Technologies, Inc., Thermo Fisher Scientific Inc., and SCIEX (Danaher Corporation), among others whose strong presence and continuous innovation drive growth of the mass spectrometry and chromatography in diagnostics market.

Recent Developments in the Mass Spectrometry and Chromatography in Diagnostics Market

  • In June 2024, Shimadzu Corporation introduced the new LCMS RX series of triple quadrupole mass spectrometry instruments.
  • In October 2023, Revvity, Inc. announced a value-added distribution agreement with SCIEX. This strategic agreement was aimed at enhancing Revvity's newborn screening products by integrating SCIEX's innovative mass spectrometry solutions, leveraging expertise and resources from both companies.
  • In August 2023, Thermo Fisher Scientific commercially launched the EXENT Solution upon receiving IVDR certification. This fully automated, integrated mass spectrometry system is designed to revolutionize the diagnosis and evaluation of patients suffering from monoclonal gammopathies, including multiple myeloma.
  • In April 2023, Waters Corporation unveiled its next-generation Xevo TQ Absolute IVD mass spectrometer, expanding its MassTrak IVD LC-MS/MS Systems family for clinical diagnostic applications.
  • In June 2022, PerkinElmer launched the GC 2400 Platform, an advanced, automated gas chromatography (GC), headspace sampler, and GC/mass spectrometry (GC/MS) solution designed to help lab teams simplify lab operations, drive precise results, and perform more flexible monitoring.

Demand - Drivers, Challenges, and Opportunities

Market Demand Drivers:

Shift from Traditional Methods to Mass Spectrometry and Chromatography in Clinical Diagnostics: The growing shift toward mass spectrometry and chromatography in clinical diagnostics represents a significant growth opportunity for the global mass spectrometry and chromatography in diagnostics market. As laboratories increasingly recognize the limitations of traditional immunoassays, the demand for more precise and efficient diagnostic technologies such as LC-MS/MS is expected to expand even more. This trend has been supported by the technology's ability to deliver accurate, robust, and cost-efficient results, which is crucial for improving patient outcomes and operational efficiency in clinical settings.

Market Challenges:

High Initial Set-Up Cost: The substantial upfront and recurring costs associated with mass spectrometry and chromatography systems present a formidable challenge for their broader adoption in clinical diagnostics. These financial barriers are particularly impactful for smaller laboratories and healthcare facilities with tight budgets, limiting their ability to invest in advanced diagnostic technologies.

Market Opportunities:

Focus on Emerging Markets for Expansion of Mass Spectrometry and Chromatography in Diagnostics: The global mass spectrometry and chromatography in diagnostics market presents substantial opportunities for growth in emerging countries, particularly through strategic focus on market expansion, growth opportunities in emerging economies, and the development of customized solutions. By focusing on affordability and accessibility, developing local partnerships and training programs, navigating regulatory requirements, and creating integrated diagnostic solutions, companies can unlock significant growth opportunities in the untapped markets of emerging countries.

How can this Report add Value to an Organization?

Product/Innovation Strategy: The global mass spectrometry and chromatography in diagnostics market has been segmented based on various categories, such as by product type, application type, sample type, testing type, and region.

Growth/Marketing Strategy: Partnerships, alliances, fundings, new offerings, and business expansions together accounted for the maximum number of key developments of the total developments in the mass spectrometry and chromatography in diagnostics market between January 2015 and June 2024.

Competitive Strategy: The global mass spectrometry and chromatography market consists of various public and few private companies. Key players in the mass spectrometry and chromatography in diagnostics market analyzed and profiled in the study involve established players that offer various kinds of products.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2023. A historical year analysis has been done for the period FY2018-FY2022. The market size has been estimated for FY2023 and projected for the period FY2024-FY2033.
  • The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of mass spectrometry and chromatography in diagnostics.
  • The market contribution of mass spectrometry and chromatography in diagnostics anticipated to be launched in the future has been calculated based on the historical analysis of the solutions.
  • Revenues of the companies have been referenced from their annual reports FY2018-FY2023.
  • The market has been mapped based on the available mass spectrometry and chromatography in diagnostics products. All the key companies with significant offerings in this field have been considered and profiled in this report.

Primary Research:

The primary sources involve industry experts in mass spectrometry and chromatography in diagnostics. Key opinion leaders (KOLs) such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of the report's segmentation and key qualitative findings
  • understanding the competitive landscape and business model
  • current and proposed production values of a product by market players
  • validation of the numbers of the different segments of the market in focus
  • percentage split of individual markets for regional analysis

Secondary Research:

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players of the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

The mass spectrometry and chromatography in diagnostics market (by product type) dominates by mass spectrometry and chromatography segment, securing a share of 85.34% in 2023. Sample preparation, on the other hand, accounted for approximately 14.66% of the market share in 2023.

Some prominent names established in this market are:

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • Tecan Group Ltd.
  • Danaher Corporation
  • Shimadzu Corporation
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • Restek Corporation
  • Gerstel GmbH & Co. KG
  • Phenomenex Inc. (Danaher Corporation)
  • Bruker Corporation
  • New England Biolabs
  • Hamilton Company
  • Avantor, Inc. (VWR International, LLC.)
  • Chromsystems Instruments & Chemicals GmbH
  • RECIPE Chemicals + Instruments GmbH
  • Zivak
  • SENTINEL CH. SpA

Table of Contents

Executive Summary

Scope and Definition

1 Global Mass Spectrometry and Chromatography in Diagnostics Market: Industry Outlook

  • 1.1 Market Overview
  • 1.2 Key Trends
    • 1.2.1 Shift toward Utilization of Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) as Standard Technique in Diagnostics
    • 1.2.2 Utilization of Automated Sample Preparation Technologies
  • 1.3 Opportunity Assessment of Key Trends
  • 1.4 Product Benchmarking
  • 1.5 Regulatory Landscape
    • 1.5.1 Regulatory Framework in the U.S.
      • 1.5.1.1 Recommendations for Diagnostic Approval
    • 1.5.2 Regulatory Framework in Europe
      • 1.5.2.1 Recommendations for Diagnostic Approval
    • 1.5.3 Regulatory Framework in Asia-Pacific
      • 1.5.3.1 China

2 Global Mass Spectrometry and Chromatography in Diagnostics Market: Market Dynamics

  • 2.1 Impact Analysis
  • 2.2 Market Drivers
    • 2.2.1 Continuous Technological Advancements in Mass Spectrometry and Chromatography Instruments
    • 2.2.2 Shift from Traditional Methods to Mass Spectrometry and Chromatography in Clinical Diagnostics
  • 2.3 Market Restraints
    • 2.3.1 High Initial Set-Up Cost
    • 2.3.2 Skill Gap and Dearth Skilled Professionals
  • 2.4 Market Opportunities
    • 2.4.1 Focus on Emerging Markets for Expansion of Mass Spectrometry and Chromatography in Diagnostics

3 Global Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type)

  • 3.1 Product Type Summary
  • 3.2 Growth-Share Matrix
  • 3.3 Sample Preparation
    • 3.3.1 Instruments
      • 3.3.1.1 Manual Sample Preparation Instrument
      • 3.3.1.2 Automated Sample Preparation Instrument
      • 3.3.1.3 Integrated Sample Preparation Instrument
    • 3.3.2 Reagents and Kits
      • 3.3.2.1 Sample Lysis and Extraction Kits
      • 3.3.2.2 Depletion and Enrichment Kits
      • 3.3.2.3 Clean-Up Kits
      • 3.3.2.4 Digestion Kits
      • 3.3.2.5 Accessories
  • 3.4 Mass Spectrometry and Chromatography
    • 3.4.1 Consumables
      • 3.4.1.1 Kits
      • 3.4.1.2 Calibration Solutions
      • 3.4.1.3 Controls and Standards
      • 3.4.1.4 Solvents
      • 3.4.1.5 Columns
      • 3.4.1.6 Vials
    • 3.4.2 Instruments
      • 3.4.2.1 Mass Spectrometry
      • 3.4.2.2 Liquid Chromatography
      • 3.4.2.3 Gas Chromatography
      • 3.4.2.4 Hybrid Mass Spectrometry
    • 3.4.3 Data Analysis Software

4 Global Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type)

  • 4.1 Application Type Summary
  • 4.2 Growth-Share Matrix
  • 4.3 Therapeutic Drug Monitoring
  • 4.4 Vitamins
    • 4.4.1 Vitamin-A
    • 4.4.2 Vitamin-B1
    • 4.4.3 Vitamin-B6
    • 4.4.4 Vitamin-E
    • 4.4.5 Others
  • 4.5 Hormones
    • 4.5.1 Metanephrines
    • 4.5.2 Catecholamines
    • 4.5.3 Steroids
    • 4.5.4 Others
  • 4.6 Methylmalonic Acid (MMA)
  • 4.7 Immunosuppressants
  • 4.8 Others

5 Global Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Type)

  • 5.1 Sample Type Summary
  • 5.2 Growth-Share Matrix
  • 5.3 Blood
  • 5.4 Urine
  • 5.5 Serum
  • 5.6 Plasma
  • 5.7 Saliva

6 Global Mass Spectrometry and Chromatography in Diagnostics Market (by Testing Type)

  • 6.1 Testing Type Summary
  • 6.2 Growth-Share Matrix
  • 6.3 Laboratory-Developed Tests
  • 6.4 Commercial Assays

7 Global Mass Spectrometry and Chromatography in Diagnostics Market (by Region)

  • 7.1 Regional Summary
  • 7.2 Drivers and Restraints
  • 7.3 North America
    • 7.3.1 Regional Overview
    • 7.3.2 Driving Factors for Market Growth
    • 7.3.3 Factors Challenging the Market
    • 7.3.4 By Product Type
    • 7.3.5 By Application Type
    • 7.3.6 U.S.
      • 7.3.6.1 By Product Type
      • 7.3.6.2 By Application Type
    • 7.3.7 Canada
      • 7.3.7.1 By Product Type
      • 7.3.7.2 By Application Type
  • 7.4 Europe
    • 7.4.1 Regional Overview
    • 7.4.2 Driving Factors for Market Growth
    • 7.4.3 Factors Challenging the Market
    • 7.4.4 By Product Type
    • 7.4.5 By Application Type
    • 7.4.6 U.K.
      • 7.4.6.1 By Product Type
      • 7.4.6.2 By Application Type
    • 7.4.7 Germany
      • 7.4.7.1 By Product Type
      • 7.4.7.2 By Application Type
    • 7.4.8 France
      • 7.4.8.1 By Product Type
      • 7.4.8.2 By Application Type
    • 7.4.9 Italy
      • 7.4.9.1 By Product Type
      • 7.4.9.2 By Application Type
    • 7.4.10 Spain
      • 7.4.10.1 By Product Type
      • 7.4.10.2 By Application Type
    • 7.4.11 Rest-of-Europe
      • 7.4.11.1 By Product Type
      • 7.4.11.2 By Application Type
  • 7.5 Asia-Pacific
    • 7.5.1 Regional Overview
    • 7.5.2 Driving Factors for Market Growth
    • 7.5.3 Factors Challenging the Market
    • 7.5.4 By Product Type
    • 7.5.5 By Application Type
    • 7.5.6 Japan
      • 7.5.6.1 By Product Type
      • 7.5.6.2 By Application Type
    • 7.5.7 China
      • 7.5.7.1 By Product Type
      • 7.5.7.2 By Application Type
    • 7.5.8 India
      • 7.5.8.1 By Product Type
      • 7.5.8.2 By Application Type
    • 7.5.9 Rest-of-Asia-Pacific
      • 7.5.9.1 By Product Type
      • 7.5.9.2 By Application Type
  • 7.6 Latin America
    • 7.6.1 Regional Overview
    • 7.6.2 Driving Factors for Market Growth
    • 7.6.3 Factors Challenging the Market
    • 7.6.4 By Product Type
    • 7.6.5 By Application Type
    • 7.6.6 Brazil
      • 7.6.6.1 By Product Type
      • 7.6.6.2 By Application Type
    • 7.6.7 Mexico
      • 7.6.7.1 By Product Type
      • 7.6.7.2 By Application Type
    • 7.6.8 Rest-of-Latin America
      • 7.6.8.1 By Product Type
      • 7.6.8.2 By Application Type
  • 7.7 Middle East and Africa
    • 7.7.1 Regional Overview
    • 7.7.2 Driving Factors for Market Growth
    • 7.7.3 Factors Challenging the Market
    • 7.7.4 By Product Type
    • 7.7.5 By Application Type
    • 7.7.6 GCC Countries
      • 7.7.6.1 By Product Type
      • 7.7.6.2 By Application Type
    • 7.7.7 South Africa
      • 7.7.7.1 By Product Type
      • 7.7.7.2 By Application Type
    • 7.7.8 Rest-of-Middle East and Africa
      • 7.7.8.1 By Product Type
      • 7.7.8.2 By Application Type

8 Global Mass Spectrometry and Chromatography in Diagnostics Market: Competitive Benchmarking and Company Profile

  • 8.1 Competitive Landscape
    • 8.1.1 Partnerships, Alliances, and Business Expansions
    • 8.1.2 New Offerings
    • 8.1.3 Mergers and Acquisitions
    • 8.1.4 Regulatory Approvals
  • 8.2 Key Strategies and Development
  • 8.3 Company Competition Matrix
  • 8.4 Company Share Analysis
  • 8.5 Company Profiles
    • 8.5.1 Agilent Technologies, Inc.
      • 8.5.1.1 Overview
      • 8.5.1.2 Top Products
      • 8.5.1.3 Top Competitors
      • 8.5.1.4 Top Customers
      • 8.5.1.5 Key Personnel
      • 8.5.1.6 Analyst View
    • 8.5.2 Thermo Fisher Scientific, Inc.
      • 8.5.2.1 Overview
      • 8.5.2.2 Top Products
      • 8.5.2.3 Top Competitors
      • 8.5.2.4 Top Customers
      • 8.5.2.5 Key Personnel
      • 8.5.2.6 Analyst View
    • 8.5.3 Waters Corporation
      • 8.5.3.1 Overview
      • 8.5.3.2 Top Products
      • 8.5.3.3 Top Competitors
      • 8.5.3.4 Top Customers
      • 8.5.3.5 Key Personnel
      • 8.5.3.6 Analyst View
    • 8.5.4 Tecan Group Ltd.
      • 8.5.4.1 Overview
      • 8.5.4.2 Top Products
      • 8.5.4.3 Top Competitors
      • 8.5.4.4 Top Customers
      • 8.5.4.5 Key Personnel
      • 8.5.4.6 Analyst View
    • 8.5.5 Danaher Corporation
      • 8.5.5.1 Overview
      • 8.5.5.2 Top Products
      • 8.5.5.3 Top Competitors
      • 8.5.5.4 Top Customers
      • 8.5.5.5 Key Personnel
      • 8.5.5.6 Analyst View
    • 8.5.6 Shimadzu Corporation
      • 8.5.6.1 Overview
      • 8.5.6.2 Top Products
      • 8.5.6.3 Top Competitors
      • 8.5.6.4 Top Customers
      • 8.5.6.5 Key Personnel
      • 8.5.6.6 Analyst View
    • 8.5.7 Merck KGaA
      • 8.5.7.1 Overview
      • 8.5.7.2 Top Products
      • 8.5.7.3 Top Competitors
      • 8.5.7.4 Top Customers
      • 8.5.7.5 Key Personnel
      • 8.5.7.6 Analyst View
    • 8.5.8 Bio-Rad Laboratories, Inc.
      • 8.5.8.1 Overview
      • 8.5.8.2 Top Products
      • 8.5.8.3 Top Competitors
      • 8.5.8.4 Top Customers
      • 8.5.8.5 Key Personnel
      • 8.5.8.6 Analyst View
    • 8.5.9 PerkinElmer Inc.
      • 8.5.9.1 Overview
      • 8.5.9.2 Top Products
      • 8.5.9.3 Top Competitors
      • 8.5.9.4 Top Customers
      • 8.5.9.5 Key Personnel
      • 8.5.9.6 Analyst View
    • 8.5.10 Promega Corporation
      • 8.5.10.1 Overview
      • 8.5.10.2 Top Products
      • 8.5.10.3 Top Competitors
      • 8.5.10.4 Top Customers
      • 8.5.10.5 Key Personnel
      • 8.5.10.6 Analyst View
    • 8.5.11 Restek Corporation
      • 8.5.11.1 Overview
      • 8.5.11.2 Top Products
      • 8.5.11.3 Top Competitors
      • 8.5.11.4 Top Customers
      • 8.5.11.5 Key Personnel
      • 8.5.11.6 Analyst View
    • 8.5.12 GERSTEL GmbH & Co. KG
      • 8.5.12.1 Overview
      • 8.5.12.2 Top Products
      • 8.5.12.3 Top Competitors
      • 8.5.12.4 Top Customers
      • 8.5.12.5 Key Personnel
      • 8.5.12.6 Analyst View
    • 8.5.13 Bruker Corporation
      • 8.5.13.1 Overview
      • 8.5.13.2 Top Products
      • 8.5.13.3 Top Competitors
      • 8.5.13.4 Top Customers
      • 8.5.13.5 Key Personnel
      • 8.5.13.6 Analyst View
    • 8.5.14 New England Biolabs
      • 8.5.14.1 Overview
      • 8.5.14.2 Top Products
      • 8.5.14.3 Top Competitors
      • 8.5.14.4 Top Customers
      • 8.5.14.5 Key Personnel
      • 8.5.14.6 Analyst View
    • 8.5.15 Hamilton Company
      • 8.5.15.1 Overview
      • 8.5.15.2 Top Products
      • 8.5.15.3 Top Competitors
      • 8.5.15.4 Top Customers
      • 8.5.15.5 Key Personnel
      • 8.5.15.6 Analyst View
    • 8.5.16 Avantor, Inc. (VWR International, LLC.)
      • 8.5.16.1 Overview
      • 8.5.16.2 Top Products
      • 8.5.16.3 Top Competitors
      • 8.5.16.4 Top Customers
      • 8.5.16.5 Key Personnel
      • 8.5.16.6 Analyst View
    • 8.5.17 Chromsystems Instruments & Chemicals GmbH.
      • 8.5.17.1 Overview
      • 8.5.17.2 Top Products
      • 8.5.17.3 Top Competitors
      • 8.5.17.4 Top Customers
      • 8.5.17.5 Key Personnel
      • 8.5.17.6 Analyst View
    • 8.5.18 RECIPE Chemicals + Instruments GmbH
      • 8.5.18.1 Overview
      • 8.5.18.2 Top Products
      • 8.5.18.3 Top Competitors
      • 8.5.18.4 Top Customers
      • 8.5.18.5 Key Personnel
      • 8.5.18.6 Analyst View
    • 8.5.19 Zivak
      • 8.5.19.1 Overview
      • 8.5.19.2 Top Products
      • 8.5.19.3 Top Competitors
      • 8.5.19.4 Top Customers
      • 8.5.19.5 Key Personnel
      • 8.5.19.6 Analyst View
    • 8.5.20 SENTINEL CH. SpA
      • 8.5.20.1 Overview
      • 8.5.20.2 Top Products
      • 8.5.20.3 Top Competitors
      • 8.5.20.4 Top Customers
      • 8.5.20.5 Key Personnel
      • 8.5.20.6 Analyst View

9 Research Methodology

  • 9.1 Data Sources
    • 9.1.1 Primary Data Sources
    • 9.1.2 Secondary Data Sources
    • 9.1.3 Data Triangulation

List of Figures

  • Figure 1: Global Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2024, 2028, and 2033
  • Figure 2: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Region), $Million, 2023, 2027, and 2033
  • Figure 3: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023, 2027, and 2033
  • Figure 4: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Application), $Million, 2023, 2027, and 2033
  • Figure 5: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Type), $Million, 2023, 2027, and 2033
  • Figure 6: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Testing Type), $Million, 2023, 2027, and 2033
  • Figure 7: Product Benchmarking (Mass Spectrometry and Chromatography (by Instruments))
  • Figure 8: Regulatory Framework, U.S. FDA
  • Figure 9: EU IVD Regulation
  • Figure 10: Impact Analysis of Market Dynamics, 2023-2033
  • Figure 11: Growth-Share Analysis for Global Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), 2023-2033
  • Figure 12: Growth-Share Analysis for Global Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), 2023-2033
  • Figure 13: Growth-Share Analysis for Global Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Type), 2023-2033
  • Figure 14: Growth-Share Analysis for Global Mass Spectrometry and Chromatography in Diagnostics Market (by Testing Type), 2023-2033
  • Figure 15: U.S. Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 16: Canada Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 17: U.K. Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 18: Germany Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 19: France Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 20: Italy Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 21: Spain Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 22: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 23: Japan Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 24: China Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 25: India Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 26: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 27: Brazil Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 28: Mexico Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 29: Rest-of-Latin America Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 30: GCC Countries Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 31: South Africa Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 32: Rest-of-Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 33: Partnerships, Alliances, and Business Expansions, January 2015- June 2024
  • Figure 34: New Offerings, January 2015- June 2024
  • Figure 35: Mergers and Acquisitions, January 2015- June 2024
  • Figure 36: New Offerings, January 2015- June 2024
  • Figure 37: Global Mass Spectrometry and Chromatography in Diagnostics Market, Company Competition Matrix
  • Figure 38: Global Mass Spectrometry and Chromatography in Diagnostics Market, % Share, 2023
  • Figure 39: Data Triangulation
  • Figure 40: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Current State and Future Potential of Key Trends in the Global Mass Spectrometry and Chromatography in Diagnostics Market
  • Table 3: Immunoassays vs. Mass spectrometry and Chromatography-Based Methods
  • Table 4: Cost Breakdown for the Acquisition of a Mass Spectrometer System
  • Table 5: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 6: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 7: Global Mass Spectrometry and Chromatography in Diagnostics Market, Sample Preparation (by Instruments), $Million, 2023-2033
  • Table 8: Global Mass Spectrometry and Chromatography in Diagnostics Market, Sample Preparation (by Reagents and Kits), $Million, 2023-2033
  • Table 9: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 10: Global Mass Spectrometry and Chromatography in Diagnostics Market, Mass Spectrometry and Chromatography, (by Consumables), $Million, 2023-2033
  • Table 11: Global Mass Spectrometry and Chromatography in Diagnostics Market, Mass Spectrometry and Chromatography, (by Instruments), $Million, 2023-2033
  • Table 12: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 13: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 14: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 15: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Type), $Million, 2023-2033
  • Table 16: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Testing Type), $Million, 2023-2033
  • Table 17: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Region), $Million, 2023-2033
  • Table 18: North America Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 19: North America Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 20: North America Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 21: North America Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 22: North America Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 23: North America Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 24: U.S. Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 25: U.S. Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 26: U.S. Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 27: U.S. Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 28: U.S. Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 29: U.S. Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 30: Canada Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 31: Canada Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 32: Canada Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 33: Canada Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 34: Canada Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 35: Canada Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 36: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 37: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 38: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 39: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 40: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 41: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 42: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 43: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 44: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 45: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 46: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 47: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 48: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 49: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 50: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 51: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 52: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 53: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 54: France Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 55: France Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 56: France Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 57: France Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 58: France Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 59: France Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 60: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 61: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 62: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 63: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 64: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 65: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 66: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 67: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 68: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 69: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 70: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 71: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 72: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 73: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 74: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 75: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 76: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 77: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 78: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 79: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 80: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 81: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 82: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 83: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 84: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 85: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 86: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 87: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 88: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 89: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 90: China Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 91: China Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 92: China Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 93: China Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 94: China Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 95: China Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 96: India Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 97: India Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 98: India Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 99: India Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 100: India Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 101: India Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 102: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 103: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 104: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 105: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 106: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 107: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 108: Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 109: Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 110: Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 111: Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 112: Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 113: Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 114: Brazil Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 115: Brazil Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 116: Brazil Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 117: Brazil Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 118: Brazil Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 119: Brazil Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 120: Mexico Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 121: Mexico Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 122: Mexico Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 123: Mexico Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 124: Mexico Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 125: Mexico Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 126: Rest-of-Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 127: Rest-of-Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 128: Rest-of-Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 129: Rest-of-Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 130: Rest-of-Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 131: Rest-of-Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 132: Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 133: Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 134: Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 135: Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 136: Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 137: Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 138: GCC Countries Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 139: GCC Countries Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 140: GCC Countries Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 141: GCC Countries Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 142: GCC Countries Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 143: GCC Countries Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 144: South Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 145: South Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 146: South Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 147: South Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 148: South Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 149: South Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 150: Rest-of-Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 151: Rest-of-Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 152: Rest-of-Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 153: Rest-of-Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 154: Rest-of-Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 155: Rest-of-Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 156: Global Mass Spectrometry and Chromatography in Diagnostics Market, Key Development Analysis, January 2015-June 2024